| 标题 |
Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Pablo Mora; Vanita R Aroda; Marisse Asong; Matthias Blüher; Line Dam Heftdal; et al 出版日期:2026-07-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)